2021 Anti-Doping Testing Figures / World Anti-Doping Agency (WADA). - Montreal : WADA, 2023
Contents:
- Executive Summary - pp. 2-9 (7 pages)
- Laboratory Report -– pp. 10-39 (30 pages)
- Sport Report - pp. 40-153 (114 pages)
- Testing Authority Report - pp. 154-267 (114 pages)
- ABP Report-Blood Analysis - pp. 268-311 (44 pages)
Report Highlights:
- A 61.2% increase in the number of samples (both urine and non-ABP blood samples) analyzed
and reported into ADAMS: 149,758 in 2020 to 241,430 in 2021. - An increase in the total number of samples analyzed and reported by nearly all WADAaccredited
laboratories and WADA-approved laboratories into ADAMS in 2021 compared to 2020. - An increase in the total number and percentage of non-ABP blood samples analyzed: 7.3%
(10,940 of 149,758 samples) in 2020 to 9.3% (22,398 Blood + DBS samples out of 241,430). - An increase of 36% in the number of ABP blood samples analyzed: 22,666 in 2020 to 30,821
in 2021. - A decrease in the total percentage of AAFs: 0.67% in 2020 (1,009 AAFs from 149,758
samples) to 0.65% (1,560 AAFs from 241,430 samples). - An increase in the total number of AAFs for growth hormone (GH): 1 in 2020 to 7 in 2021,
including the first reported AAF for a GH biomarker. - A 46% decrease in the overall number of samples analyzed: 278,047 in 2019 to 149,758 in 2020.
- A decrease in the total percentage of Adverse Analytical Findings (AAFs): 0.97% in 2019 (2,702 AAFs from 278,047 samples) to 0.67% in 2020 (1,009 AAFs from 149,758 samples).
- All WADA-accredited Laboratories saw a decrease in the total number of samples recorded.
- A decrease in the total number and percentage of non-Athlete Biological Passport (ABP) blood samples analyzed: 9.1% in 2019 (25,339 of 278,047) and 7.3% (10,940 of 149,758) in 2020.
- A decrease of 38% in the number of ABP blood samples tested: 36,401 in 2019 to 22,666 in 2020.
The World Anti-Doping Agency (WADA) has publishes its 2021 Testing Figures Report (2021 Report), which summarizes the results of all the samples WADA-accredited laboratories analyzed and reported in WADA’s Anti-Doping Administration and Management System (ADAMS) in 2021.
This is the first set of global testing figures under the 2021 World Anti-Doping Code (Code) that came into effect in January 2021. The 2021 Report – which includes an Executive Summary and sub-reports by Laboratory, Sport, Testing Authority and Athlete Biological Passport (ABP) Blood Analysis – includes in- and out-of-competition urine samples, blood and ABP blood data, and the resulting Adverse Analytical Findings (AAFs) and Atypical Findings (ATFs).
